News & Updates
Filter by Specialty:
Obese breast cancer patients on T-DM1 prone to more treatment adjustments
More treatment modifications secondary to adverse events appear necessary among obese patients receiving ado-trastuzumab emtansine (T-DM1), an antibody-drug conjugate indicated for the treatment of HER2-positive breast cancer, relative to nonobese counterparts, reports a study.
Obese breast cancer patients on T-DM1 prone to more treatment adjustments
04 Feb 2022Systemic inflammation mediates obesity-related severe COVID-19
Systemic inflammation plays a significant role in severe COVID-19 associated with obesity, particularly in patients aged <65 years, as captured by peak C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR), a study has found.
Systemic inflammation mediates obesity-related severe COVID-19
04 Feb 2022Singapore’s home test catches smell, taste loss in COVID-19 patients
The Singapore Smell and Taste Test (SSTT), a personal testing kit for the daily home- and self-assessment of smelling and tasting functions, can objectively assess sensory losses in patients with the coronavirus disease 2019 (COVID-19) and align well with self-reported measures of sensory function, according to a recent study.